Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-CRM vs Licensed Vaccine in Children 2-10 Years
NCT00616421Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of Meningococcal A, C, Y and W-135 conjugate vaccine in meningococcal infection (3 arms), sponsored by Novartis. Primary endpoint: Percentages of Subjects With hSBA Seroresponse. Started Mar 2008; status: completed.
02
Drugs
Meningococcal A, C, Y and W-135 conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00616421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616421.